Home › Kanser sa Suso › District of Columbia
Pag-aaral pangklinika para sa Kanser sa Suso sa District of Columbia
28 pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa mga site sa District of Columbia.
Mga Lungsod sa District of Columbia
Opisyal na teksto ng pag-aaral (English)
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- Georgetown University Medical Center, Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06982521Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
- Georgetown University Lombardi Cancer Center, Washington D.C.
Nagre-recruitPhase 3
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05827081Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069Older Breast Cancer Patients: Risk for Cognitive Decline
- Georgetown University, Washington D.C.
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 60 hanggang 105 · Kababaihan · Na-update Set 28, 2026 · NCT03451383ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- The George Washington Medical facility Associates, Washington D.C.
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07007559A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- MedStar Washington Hospital Center, Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07174336A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
- Georgetown Uni Hospital, Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05894239Identifying Patterns in the Breath of Individuals With Breast Cancer
- GW Comprehensive Breast Center, Washington D.C.
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 74 · Kababaihan · Na-update Set 18, 2026 · NCT06512350A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- Georgetown University Medical Center, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
- at 1 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06492616A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
- MedStar Heart & Vascular Institute (MHVI) - MedStar Washington Hospital Center, Washington D.C.
Nagre-recruitPhase 1
Edad 18 hanggang 55 · Kababaihan · Na-update Set 9, 2026 · NCT07310420Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
- Georgetown University, Washington D.C.
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT05315700Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- at 2 pa
Nagre-recruitPhase 3
Edad 18 hanggang 60 · Kababaihan · Na-update Set 2, 2026 · NCT05879926TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
- Georgetown University Medical Center, Washington D.C.
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT06533826Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming
- Sibley Memorial Hospital, Washington D.C.
Nagre-recruit
Edad 18 pataas · Kababaihan · Na-update Ago 21, 2026 · NCT06536881Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- Sibley Memorial Hospital, Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT06500481Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
- Johns Hopkins Medicine - Kimmel Cancer Center-Sibley Memorial Hospital, Washington D.C.
Nagre-recruitPhase 3
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT05232916E-Mindfulness Approaches for Living After Breast Cancer
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
Nagre-recruitPhase 3
Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06748222I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- Georgetown University Medical Center, Washington D.C.
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT01042379A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
- MedStar Washington Hospital Center, Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT07062965De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- George Washington University Medical Center, Washington D.C.
Nagre-recruitPhase 3
Edad 50 hanggang 70 · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT04852887Cancer Experience Registry (CER) for Cancer Patients and Caregivers
- Cancer Support Community Research & Training Institute, Washington D.C.
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT02333604Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
- Georgetown University, Washington D.C.
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 9, 2026 · NCT04841148Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
- George Washington-Medical Faculty Associates, Washington D.C.
Nagre-recruitPhase 2
Edad 21 pataas · Lahat ng kasarian · Na-update Mar 3, 2026 · NCT06806930The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
- Sibley Memorial Hospital, Washington D.C.
Nagre-recruit
Edad 18 pataas · Kababaihan · Na-update Peb 23, 2026 · NCT05780814Study in Patients With Breast Cancer Leptomeningeal Metastasis
- Sibley Memorial Hospital, Washington D.C.
Nagre-recruitObservasyonal na pag-aaral
18 Weeks · Lahat ng kasarian · Na-update Nob 28, 2025 · NCT06638294The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
- Georgetown University, Washington D.C.
Nagre-recruit
Edad 18 hanggang 74 · Kababaihan · Na-update Set 30, 2025 · NCT06892275CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Kababaihan · Na-update Ago 28, 2025 · NCT05130606CtDNA Based MRD Testing for NAC Monitoring in TNBC
- George Washington University, Washington D.C.
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Kababaihan · Na-update Ene 7, 2025 · NCT06230185Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.